Year: 2011
Type: conference-abstract
Study design: Observational Study
Abstract: BACKGROUND: Exacerbations represent a major source of morbidity and mortality in asthma and are a prominent feature of poorly controlled, difficult-to-treat disease. OBJECTIVE: The goal of our study was to provide a detailed characterization of the frequent exacerbator phenotype and to identify risk factors associated with frequent and seasonal exacerbations. METHODS: Ninety-three severe asthmatics (SA) and 76 mild-to-moderate patients (MA) were screened and prospectively followed up for 1 year (NCT00555607). Medical history, baseline clinical data and biomarkers were used to assess risk factors for frequent exacerbations. RESULTS: During the study, 104 exacerbations were recorded in the SA group and 18 in the MA. Frequent exacerbators were characterized by use of higher doses of inhaled (1700 vs. 800 μg) and oral (6.7 vs. 1.7 mg) glucocorticosteroids, worse asthma control (ACQ score 2.3 vs. 1.4), lower quality of life (SGRQ score 48.5 vs. 33.3), higher sputum eosinophils (25.7% vs. 8.2%) and a more rapid decline in FEV1 /FVC ratio (-0.07 vs. -0.01 ΔFEV1 /FVC, frequent vs. non-frequent, respectively, P < 0.05). Exhaled NO > 45 p.p.b. and a history of smoking were associated with an increased risk of frequent exacerbations (odds ratios: 4.32 and 2.90 respectively). CONCLUSION AND CLINICAL RELEVANCE: We were able to distinguish and characterize a subphenotype of asthma subjects--frequent exacerbators--who are significantly more prone to exacerbations. Patients with FeNO > 45 p.p.b. and a history of smoking are at increased risk of frequent exacerbations and require careful monitoring in clinical practice.
Source: European Respiratory Journal
Authors: M. Kupczyk, A. ten Brinke, P. J. Sterk, E. H. Bel, A. Papi, P. Chanez, E. Nizankowska‐Mogilnicka, M. Gjomarkaj, M. Gaga, G. Brusselle, B. Dahlén, S.‐E. Dahlén, the BIOAIR investigators
Institutions: Karolinska Institutet, Medical University of Lodz, Medisch Centrum Leeuwarden, Amsterdam UMC Location University of Amsterdam, University of Amsterdam, University of Ferrara, Aix-Marseille Université, Jagiellonian University, Istituto di Biomedicina e di Immunologia Molecolare Alberto Monroy, National Research Council, National and Kapodistrian University of Athens, Ghent University Hospital
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W1961535972
